Nestle sells peanut allergen Palforzia
(dpa-AFX) Food giant Nestlé has found a buyer for its peanut allergy drug Palforzia. The business, which Nestlé put in the shop window last November as part of a strategic review, will go to Stallergenes Greer, a biopharma company headquartered in London. Under the agreement, Stallergenes Greer will make milestone payments and ongoing royalties to Nestlé, according to a statement. However, no further financial details were provided. The transaction was completed immediately upon signing, it adds.
The drug, which has been approved in the EU and U.S. since 2020 and was developed by Nestlé subsidiary Aimmune, has sold less well than Nestlé expected. That's why the company had already announced last fall that it would seek a buyer for the drug.
Palforzia is an immunotherapy that can be used in children diagnosed with peanut allergy and administered to adults in conjunction with a peanut-free diet. Nestlé had acquired the developer Aimmune in 2020 for 2.3 billion Swiss francs.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Other news from the department business & finance

Get the food & beverage industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

TEEKANNE is a Best Managed Company 2024

Agricultural research and food sciences - University of Hohenheim remains Germany's No. 1 in the NTU ranking

Avian flu: pasteurized milk remains safe - Researchers find no active H5N1 viruses after pasteurization

Popcorn from the USA - the GMO-free snack

Often unbalanced: vegan meat substitutes
High-fat diet disrupts brain maturation
General Mills Reports Q4 Adj. EPS Of $0.75

Gen Z drive demand for alcohol reduction

Preventing the spread of plant pandemics - New tools needed to curb threats to global food security

Breweries still under high cost pressure - Inflation and weak consumer sentiment hit the industry

Pesticides in food: latest data published - It gives a snapshot of the residue levels found in a selection of commonly consumed products
